Join the club for FREE to access the whole archive and other member benefits.

Leucadia Therapeutics

Company developing an early diagnostic and a device to prevent Alzheimer's disease

Leucadia Therapeutics Inc is privately-held, pre-clinical stage company focused on Alzheimer's disease prevention and treatment. The company is developing a diagnostic algorithm for Alzheimer's disease risk based on big data. A therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment(MCI) from progressing to Alzheimer's disease.

Visit website: https://www.leucadiatx.com/

 leucadia-therapeutics

 LeucadiaT

Details last updated 04-May-2019

People at Leucadia Therapeutics

Doug Ethell

Founder and CEO at Leucadia Therapeutics

Leucadia Therapeutics News

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Fight Aging! - 16-Jun-2023

Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! - 20-Jan-2020

When some of these succeed in human trials even more money will pile in to fund further advances

Undoing Aging 2018: an initiative to remember

Undoing Aging 2018: an initiative to remember

Long Long Life - 22-Mar-2018

45 speakers, scientists and entrepreneurs, presented their work. Attended by 350 people from a t...